Analysis Article • Jul 14

Over the last 7 days, the Biotech industry has dropped 1.8%, driven by Lakefront Biotherapeutics declining 2.2%. Meanwhile, Vivoryon Therapeutics actually outperformed within the industry, gaining 27% in the last week. This takes the industry's 12 month performance to a gain of 11%. Looking forward, earnings are forecast to decline by 20% per year.
Has the Dutch Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 19 Jul 2026 | €2.6b | €1.4b | €489.9m | 39.2x | 5.2x | 1.9x |
| Tue, 16 Jun 2026 | €2.5b | €1.4b | €489.7m | 38.5x | 5x | 1.8x |
| Thu, 14 May 2026 | €2.4b | €1.4b | €489.6m | 39.7x | 5x | 1.8x |
| Sat, 11 Apr 2026 | €2.7b | €1.4b | €309.4m | 215.7x | 8.7x | 1.9x |
| Mon, 09 Mar 2026 | €2.8b | €1.4b | €307.3m | 1387.5x | 9.1x | 2x |
| Wed, 04 Feb 2026 | €3.0b | €593.4m | -€456,031,828.00 | 3084.7x | -6.5x | 5x |
| Fri, 02 Jan 2026 | €2.9b | €595.4m | -€456,029,765.20 | 3004x | -6.3x | 4.8x |
| Sun, 30 Nov 2025 | €2.8b | €599.1m | -€456,025,792.40 | 2996.9x | -6.2x | 4.7x |
| Tue, 28 Oct 2025 | €2.6b | €567.4m | -€307,971,520.00 | n/a | -8.5x | 4.6x |
| Thu, 25 Sep 2025 | €2.8b | €565.1m | -€307,917,400.00 | n/a | -9x | 4.9x |
| Sat, 23 Aug 2025 | €2.6b | €565.6m | -€316,014,060.00 | n/a | -8.4x | 4.7x |
| Mon, 21 Jul 2025 | €2.4b | €564.2m | -€212,049,376.00 | n/a | -11.4x | 4.3x |
| Wed, 18 Jun 2025 | €2.3b | €567.4m | -€212,193,318.40 | n/a | -10.8x | 4x |
| Fri, 16 May 2025 | €2.2b | €575.0m | -€212,526,361.60 | n/a | -10.3x | 3.8x |
| Sun, 13 Apr 2025 | €1.9b | €537.7m | -€11,723,393.80 | n/a | -159.1x | 3.5x |
| Tue, 11 Mar 2025 | €2.1b | €539.5m | -€17,741,540.50 | n/a | -117.7x | 3.9x |
| Thu, 06 Feb 2025 | €2.0b | €534.4m | -€77,721,080.00 | n/a | -25.9x | 3.8x |
| Sat, 04 Jan 2025 | €2.4b | €537.9m | -€77,940,302.90 | n/a | -31.4x | 4.5x |
| Mon, 02 Dec 2024 | €2.2b | €530.1m | -€77,453,735.00 | n/a | -28.7x | 4.2x |
| Wed, 30 Oct 2024 | €2.3b | €525.7m | €15.0m | 56.1x | 154.3x | 4.4x |
| Fri, 27 Sep 2024 | €2.2b | €509.7m | €19.6m | 54.6x | 112.6x | 4.3x |
| Sun, 25 Aug 2024 | €2.0b | €509.4m | €19.6m | 48.8x | 103.7x | 4x |
| Tue, 23 Jul 2024 | €2.2b | €480.9m | €20.8m | 52.9x | 103.6x | 4.5x |
| Thu, 20 Jun 2024 | €2.1b | €484.0m | €20.7m | 52.1x | 101.6x | 4.3x |
| Sat, 18 May 2024 | €2.4b | €481.2m | €20.8m | 59x | 114.5x | 4.9x |
| Mon, 15 Apr 2024 | €2.6b | €470.3m | -€40,191,065.20 | n/a | -64x | 5.5x |
| Wed, 13 Mar 2024 | €2.8b | €439.9m | -€50,463,941.50 | n/a | -56.2x | 6.4x |
| Fri, 09 Feb 2024 | €3.3b | €746.9m | -€199,825,040.00 | n/a | -16.6x | 4.5x |
| Sun, 07 Jan 2024 | €3.4b | €743.9m | -€199,516,270.00 | n/a | -17.1x | 4.6x |
| Tue, 05 Dec 2023 | €3.3b | €746.2m | -€199,745,642.00 | n/a | -16.3x | 4.4x |
| Thu, 02 Nov 2023 | €3.0b | €767.6m | -€204,557,579.00 | n/a | -14.7x | 3.9x |
| Sat, 30 Sep 2023 | €3.2b | €755.1m | -€199,149,010.00 | n/a | -16.3x | 4.3x |
| Mon, 28 Aug 2023 | €3.4b | €751.1m | -€200,699,143.00 | n/a | -16.8x | 4.5x |
| Wed, 26 Jul 2023 | €3.5b | €730.2m | -€211,435,276.00 | n/a | -16.7x | 4.8x |
-16.7x
Which industries have driven the changes within the Dutch Healthcare industry?
| NL Market | -1.01% | |
| Healthcare | -1.76% | |
| Biotech | -2.58% | |
| Biotech | -2.58% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| No data available | |||||